appears in the following:

Democrats may make some progress toward lowering high drug prices

Thursday, August 04, 2022

The cost of prescription drugs have been a political issue for years. If Congress passes the Reduce Inflation Act, a provision would allow Medicare, for the first time, to negotiate drug prices.

Comment

5 things to know about the FDA's flawed approach to accelerated drug approvals

Monday, July 25, 2022

An NPR investigation found stalled confirmatory trials and lax enforcement are plaguing the FDA's accelerated approval of drugs for urgent medical needs.

Comment

Drugmakers are slow to prove medicines that got a fast track to market really work

Friday, July 22, 2022

Stalled confirmatory trials and lax enforcement plague the Food and Drug Administration's accelerated approval pathway for pharmaceuticals that target urgent medical needs.

Comment

Some fast-tracked drugs are tardy doing their trials to get regular FDA approval

Thursday, July 21, 2022

Stalled confirmatory trials and lax enforcement plague the Food and Drug Administration's accelerated approval pathway for pharmaceuticals that target urgent medical needs.

Comment

2 House subcommittees are trying to get answers about the baby formula shortage

Wednesday, May 25, 2022

Two House subcommittees are holding hearings on the baby formula crisis. One will focus on the Food and Drug Administration and the formula makers. The other will look at the effects of the shortage.

Comment

White House invokes the Defense Production Act for the baby formula shortage

Thursday, May 19, 2022

The Biden administration says help is on the way to address the nationwide baby formula shortage. How would the Defense Production Act, a legal vestige of the Cold War era, help?

Comment

Feds' contract with Pfizer for Paxlovid has some surprises

Tuesday, February 01, 2022

NPR has obtained the government's $5.3 billion contract for the first 10 million courses of Paxlovid, an antiviral pill for COVID-19. Here's what's in it.

Comment

Biden promised a billion COVID tests. Contracts to buy them are being announced

Friday, January 14, 2022

The Biden administration wants to buy and send a billion free at-home COVID tests to Americans. Here's what we know so far about the contracts in terms of price, timeline and more.

Comment

The COVID antiviral drugs are here but they're scarce. Here's what to know

Friday, December 31, 2021

Paxlovid and molnupiravir have been authorized for emergency use to keep COVID-19 patients out of the hospital, but don't expect to be able to go to your usual pharmacy and get them.

Comment

Omicron boosters are in the works, but will they be needed?

Tuesday, December 07, 2021

Omicron has many more mutations than previous variants of concern, a fact that raises questions about how effective existing vaccines will be against the new form of the coronavirus.

Comment

What the omicron variant might mean for current — and future — vaccines

Tuesday, December 07, 2021

Former scientific head of Operation Warp Speed Moncef Slaoui explains why he is confident in existing vaccines' protection against omicron and how soon a variant-specific booster could be developed.

Comment

What you need to know about the COVID-19 omicron variant

Sunday, November 28, 2021

There's a new, heavily mutated COVID-19 variant called omicron. Scientists tell us what's known so far about it, what's not yet known, and what this all means for public health.

Comment

COVID vaccines are set to be among the most lucrative pharmaceutical products ever

Wednesday, November 24, 2021

How much money have Pfizer and Moderna made off their COVID-19 vaccines? They're shaping up to be the most lucrative pharmaceutical products ever.

Comment

Pfizer says it will share the rights to its COVID-19 pill

Tuesday, November 16, 2021

Pfizer says it is willing to share rights to its COVID-19 pill, Paxlovid. It's an oral antiviral drug that can be taken outside the hospital, which could be a help to low income countries.

Comment

Drugmaker drops cheaper version of drug, leaving patients stuck with pricier one

Saturday, November 06, 2021

Kids who need hormone-blocking drugs to prevent premature puberty — or delay it if they're trans — have lost a more affordable option. The remaining nearly identical drug costs eight times more.

Comment

With an off-label drug discontinued, families' other option costs thousands more

Monday, November 01, 2021

Kids who need a hormone-blocking drug to prevent premature puberty have lost an off-label option. The company that makes the medicine, which is 1/8 the cost of the FDA-approved version, withdrew it.

Comment

CDC Warns Against Off-Label Use Of COVID Vaccine

Thursday, September 02, 2021

Using the COVID vaccine "off-label" — whether that's for booster shots or young children — may be tempting to some vaccine providers, but the CDC warns it could get them into trouble.

Comment

The U.S. Paid Billions To Get Enough COVID Vaccines Last Fall. What Went Wrong?

Wednesday, August 25, 2021

Immediately after the Food and Drug Administration authorized Pfizer's vaccine, the company delivered fewer doses than its government contract projected. Federal officials say they didn't know why.

Comment

COVID Booster Shots Are Coming. Here's What You Need To Know

Thursday, August 19, 2021

If all goes to plan, Americans who got Pfizer or Moderna shots can get a third dose eight months after their last jab. Here's why health officials think you'll need one.

Comment

Lawmakers Grill Vaccine Factory Executives About Manufacturing Mistakes

Wednesday, May 19, 2021

House subcommittee members questioned why Emergent BioSoultions awarded bonuses to executives despite quality problems than hindered production of Johnson & Johnson's COVID-19 vaccine.

Comment